Chronic Microcytic Anemia ICD-10 Codes: D50, D56, D63

·

Share

Chronic microcytic anemia has no single ICD-10 code of its own. It is coded by its cause: iron deficiency anemia falls under D50, thalassemia under D56, anemia of chronic disease under D63, and sideroblastic anemia under D64.0–D64.3. When the cause is not yet known, a microcytic anemia is usually indexed to D50.9 (iron deficiency anemia, unspecified) until testing clarifies it. Getting the cause right therefore matters for both treatment and accurate coding.

This guide explains what microcytic anemia is, how clinicians work out the cause, which codes apply to each, and how the condition is treated.

What Is Chronic Microcytic Anemia?

Anemia means a low hemoglobin level. Microcytic means the red cells are smaller than normal red blood cells, defined as a mean corpuscular volume (MCV) below about 80 femtoliters (fL) in adults. The cells are often also pale, or hypochromic, because each carries less hemoglobin.

Small red cells almost always point to a problem making hemoglobin. Hemoglobin needs iron, a ring structure called heme, and globin protein chains. A shortage or defect in any of these leaves the developing cell with less to fill it, and it divides an extra time, ending up smaller. “Chronic” simply means the anemia has developed over months or years rather than suddenly.

Causes of Microcytic Anemia

Clinicians often use the memory aid “TAILS” for the main causes: Thalassemia, Anemia of chronic disease, Iron deficiency, Lead poisoning, and Sideroblastic anemia.

  • Iron deficiency is by far the most common cause. In adults it usually reflects blood loss, from heavy periods or from the gut, or poor absorption, as in celiac disease or after gastric surgery.
  • Thalassemia is an inherited reduction in globin chain production. Carriers (thalassemia trait) often have very small cells with only mild anemia.
  • Anemia of chronic disease is usually normocytic but becomes microcytic in long-standing inflammation, because the hormone hepcidin locks iron away in storage.
  • Lead poisoning blocks several steps in heme production.
  • Sideroblastic anemia, inherited or acquired, traps iron in the mitochondria of developing red cells. Acquired forms can follow alcohol, certain drugs, copper deficiency, or a marrow disorder.

ICD-10 Codes for Microcytic Anemia

The table below lists the codes most often used for microcytic anemia in ICD-10-CM, the US clinical version of ICD-10. Coders should confirm the final code against the current code set and documentation.

Cause ICD-10-CM code Notes
Iron deficiency anemia secondary to chronic blood loss D50.0 Use when blood loss is documented as the cause
Other iron deficiency anemias D50.8 For example, inadequate dietary iron
Iron deficiency anemia, unspecified D50.9 Also the index default for microcytic hypochromic anemia
Alpha thalassemia D56.0 Excludes the trait
Beta thalassemia D56.1 Major and intermedia forms
Thalassemia minor (trait) D56.3 Carrier state with small red cells
Anemia in chronic kidney disease D63.1 Code the kidney disease first
Anemia in other chronic diseases D63.8 Code the underlying disease first
Hereditary sideroblastic anemia D64.0 Rare inherited forms
Secondary sideroblastic anemia due to drugs and toxins D64.2 Add the relevant drug or toxin code

Lead poisoning is coded as a toxic effect (in the T56.0 group) alongside the anemia. The general principle is to code the most specific cause that the clinical record supports, and to avoid “unspecified” codes once the workup is complete.

Signs and Symptoms

Because chronic microcytic anemia develops slowly, the body adapts, and many people feel surprisingly well until hemoglobin is quite low. Common symptoms include:

  • Tiredness, reduced exercise tolerance, and shortness of breath on exertion
  • Pale skin, pale inner eyelids, and a fast heartbeat
  • Headaches and poor concentration
  • In iron deficiency specifically: brittle or spoon-shaped nails, a sore tongue, hair thinning, restless legs, and pica, a craving for ice or non-food substances

Thalassemia trait usually causes no symptoms at all and is often found on a routine blood count.

How the Cause Is Diagnosed

The workup starts with a complete blood count (CBC) and a look at the serum ferritin, which reflects iron stores. A ferritin below about 30 ng/mL strongly suggests iron deficiency. Because ferritin rises with inflammation, a normal value does not fully exclude iron deficiency in someone who is unwell.

Test Iron deficiency Thalassemia trait Anemia of chronic disease
MCV Low Low, often very low Normal or mildly low
Red cell count Low Normal or high Low
Ferritin Low Normal Normal or high
Transferrin saturation Low Normal Low
RDW (variation in cell size) High Usually normal Usually normal

A quick screening clue is the Mentzer index: MCV divided by the red cell count. A value under 13 favors thalassemia trait, and over 13 favors iron deficiency. It is a guide, not a diagnosis. Hemoglobin electrophoresis or HPLC confirms beta thalassemia trait, while alpha thalassemia trait often needs DNA testing.

Once iron deficiency is confirmed in a man or a woman after menopause, the gut should be examined for a source of bleeding, usually with endoscopy. A blood lead level, blood smear, or bone marrow examination with iron staining is reserved for cases that remain unexplained.

Treatment and Management

Treatment depends entirely on the cause, which is why the diagnosis and the code go hand in hand.

  • Iron deficiency: oral iron, often taken once daily or on alternate days to improve absorption and reduce stomach upset. Intravenous iron is used when tablets are not tolerated, not absorbed, or not fast enough. Hemoglobin typically starts to rise within a few weeks, and treatment continues for a few months after it normalizes to refill stores. Most important, the source of iron loss must be treated.
  • Thalassemia trait: no treatment is needed, and iron should not be given unless iron deficiency is also proven. Genetic counseling matters for family planning.
  • Thalassemia major and intermedia: specialist care, which may include regular transfusions and iron chelation.
  • Anemia of chronic disease: control of the underlying condition; in chronic kidney disease, erythropoiesis-stimulating agents and iron may be used.
  • Sideroblastic anemia and lead poisoning: remove the trigger; some inherited forms respond to vitamin B6 (pyridoxine).

When to See a Doctor

See a doctor if you have ongoing fatigue, breathlessness, or pallor, or if a routine blood test shows a low MCV. Seek prompt attention for black or bloody stools, vomiting blood, unintentional weight loss, or chest pain with anemia. Never take iron long term without a confirmed diagnosis, because people with thalassemia trait or iron overload can be harmed by it. More on related conditions is in our anemia guide.

Frequently Asked Questions

What is the ICD-10 code for microcytic anemia?

There is no stand-alone code. Microcytic hypochromic anemia without a stated cause is indexed to D50.9, but once the cause is known it should be coded specifically, such as D50.0 for chronic blood loss or D56.3 for thalassemia trait.

Is microcytic anemia always iron deficiency?

No. Iron deficiency is the most common cause, but thalassemia trait, chronic inflammation, and rarer conditions also produce small red cells. A ferritin test and, if needed, hemoglobin studies separate them.

How long does it take to correct iron deficiency anemia?

Hemoglobin usually improves within two to four weeks of adequate iron and often normalizes within about two months. Iron stores take longer to rebuild, so treatment generally continues for several months.

Can thalassemia trait turn into thalassemia major?

No. Trait is a carrier state that stays mild for life. The concern is for children: if both parents carry the trait, each pregnancy has a chance of producing a child with a more severe form.

Written by
Coagulation & Thrombosis, Haematology, Platelet Biology
Contact [email protected] Website Maastricht University September 15, 2020 Thrombus heterogeneity: does it matter? Judith Cosemans holds a PhD degree (2009) in platelet biology, which focused on the dynamic regulation of thrombus stability. As a postdoc, she further developed flow chamber technology as a compatible alternative for experimental animal models of arterial thrombosis. As of April 2020, she leads the platelet…
View Full Profile →
Web Admin Avatar